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Abstract Purpose: To examine
the physical properties and chemical
composition of particles captured by
in-line microﬁlters in critically ill
children, and to investigate the
inﬂammatory and cytotoxic effects
of particles on endothelial cells
(HUVEC) and macrophages in vitro.
Methods: Prospective, observa-
tional study of microﬁlters following
their use in the pediatric intensive
care unit. In vitro model utilizing
cytokine assays to investigate the
effects of particles on human endo-
thelial cells and murine macrophages.
Results: Twenty ﬁlter membranes
from nine patients and ﬁve controls
were examined by electron micro-
scopy (EM) and energy dispersion
spectroscopy (EDX). The average
number of particles found on the
surface of the used membranes was
550 cm
2. EDX analysis conﬁrmed
silicon as a major particle constituent.
Half of the ﬁlter membranes showed
conglomerates containing an
uncountable number of smaller parti-
cles. In vitro, glass particles were
used to mimic the high silicon content
particles. HUVEC and murine mac-
rophages were exposed to different
contents of particles, and cytokine
levels were assayed to assess their
immune response. Levels of inter-
leukin-1beta, interleukin-6,
interleukin-8, and tumor necrosis
factor alpha were suppressed.
Conclusions: Particle contamina-
tion of infusion solutions exists
despite a stringent infusion regiment.
The number and composition of par-
ticles depends on the complexity of
the applied admixtures. Beyond pos-
sible physical effects, the suppression
of macrophage and endothelial cell
cytokine secretion in vitro suggests
that microparticle infusion in vivo
may have immune-modulating
effects. Further clinical trials are
necessary to determine whether par-
ticle retention by in-line ﬁltration has
an inﬂuence on the outcome of
intensive care patients.
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Introduction
One million particles per patient may be infused daily in
an intensive care setting, where a potential risk appears
against the background of debilitation and impaired host
responses [1, 2]. Mechanisms of particle damage to vari-
ous organs have been postulated, including effects on
microcirculation causing thrombi and granuloma forma-
tion [3–5]. Use of in-line ﬁltration almost completely
prevents particulate infusion [6]. Recent studies have
evaluated the clinical effect of in-line ﬁltration and
showed signiﬁcant reduction in thrombophlebitis [7] and a
trend towards reduction of complications in neonates such
as sepsis, thrombosis, and necrotizing enterocolitis [8].
Intensive Care Med (2010) 36:707–711
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intensive care unit (PICU), we carried out detailed
examinations of ﬁlters after their use. Electron micro-
scopy (EM) visualized particles adhering to the
membrane, and energy dispersion spectroscopy (EDX)
revealed their chemical compositions [9]. Based on these
data immune-modulating effects on human umbilical vein
endothelial cells (HUVEC) and murine macrophages
(RAW 264.7) were analyzed in vitro.
Materials and methods
Prior to this study, the infusion regiment in the PICU was
optimized to prevent precipitation and incompatibilities
using a computer-based analysis. Solutions and thera-
peutics were prepared according to the manufacturers’
recommendations. Approval by the ethics committee and
parental consent were obtained.
EM and EDX
Twenty-ﬁve Pall ELD96LLCE/NEO96E ﬁlters with
0.2 lm pore size (Pall, Dreieich, Germany) were ana-
lyzed. Twenty ﬁlters from nine patients were randomly
chosen after 72 h. Five unused ﬁlters served as controls
(see Table 1, ESM). For detailed information see ESM.
Cell culture
To simulate the in vivo situation, glass particles (2–
20 lm) were chosen to mimic the silicon content of
particles found on the ﬁlters. Contamination with lipo-
polysaccharide (LPS) was excluded. Inﬂammatory effects
were analyzed on RAW 264.7 (gamma NO-, ATCC
CRL-2278) and HUVEC (CC2517). Cytotoxic particle
load was determined by release of adenylatkinase (Toxi-
Light test) and lactate-dehydrogenase (LDH-cytotoxicity
test). Experiments were performed at subtoxic loads.
Cells were incubated with glass particles at contents from
0 to 500 lg/ml. Release of interleukin 1-beta (IL-1b),
interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor
necrosis factor alpha (TNFa) was measured after 4, 8,
and 24 h with ELISA kits for IL-1b (DY201), IL-6
(DY406), IL-8 (DY208), and TNFa (DY410; all kits by
R&D Duoset).
Cells were additionally incubated with 1 lg/ml LPS,
and HUVEC cells with 1 ng/ml TNFa as well. Results of
ELISA are given as the median of repeated determina-
tions. ToxiLight test results reﬂect the mean of four trials
and considered values within three standard deviations of
the controls as nontoxic. Statistics were processed by
Dunnett’s test [10].
Results
EM and EDX analysis
The average number (range) of particles on the surface of
the negative controls was 45.6 particles/cm
2 (6–93 parti-
cles/cm
2). Used ﬁlters showed a mean of 550 particles/
cm
2 (8–1,993 particles/cm
2), which was signiﬁcantly
higher than the mean particle load of controls (P\0.001).
Particle size ranged from 5 to [100 lm with the
majority between 5 and 50 lm. EDX analysis detected
silicon, carbon, oxygen, sodium, chloride, potassium,
calcium, magnesium, iron, and aluminum. Phosphorus,
thallium, ﬂuorine, chromium, copper, zinc, sulfur, barium,
and nickel were seldom found. Only carbon and oxygen
may be part of the membrane itself. Gold was added
during preparation. Silicon was the most frequently
detected element in analysis of individual particles. These
particles were notable for their angular shape and crys-
talline appearance (Fig. 1a, b).
Fifty percent of analyzed ﬁlters showed conglomerates
on the surfaces, containing uncountable numbers of par-
ticles. Figure 1c shows a conglomerate, detected on a
ﬁlter used for parenteral nutrition and heparin (ﬁlter 12,
Table 1, ESM). Parenteral nutrition was highly concen-
trated with an osmolarity [1,300 mosm/l. EDX analysis
revealed different elements as components of the con-
glomerate (e.g., carbon, sodium, potassium). It
demonstrates the spectrum of elements and is represen-
tative of other analyzed particles. Results of particle
counts and data of the applied ﬂuids/therapeutics are
shown in Table 1 of the ESM. Data suggest a correlation
between the complexity of the infusion regiment and the
particle load (Fig. 1, ESM).
Cell culture (HUVEC/RAW 264.7)
Cytotoxicity
ToxiLight and LDH-cytotoxicity tests found that particle
loads [500 lg/ml were toxic in RAW 264.7 and HU-
VEC. For detailed information on cytotoxicity tests, see
ESM.
HUVEC and IL-8 After incubation of HUVEC with
glass particles, IL-8 increased signiﬁcantly in samples of
300 lg( P\0.05) and 500 lg( P\0.01) particles/ml.
Additional stimulation of HUVEC with 1 lg/ml LPS or
1 ng/ml TNFa led to a 10-fold increase in IL-8 in samples
incubated with particle concentrations above 300 lg/ml.
Samples with particle dilution of 10 lg/ml and above
showed signiﬁcant suppression of IL-8 at 4 and 8 h after
incubation with LPS (Fig. 2, ESM). Increased IL-8 levels
were detected for 300 and 500 lg/ml (data not shown).
HUVEC and IL-1b After 8 and 24 h incubation,
concentrations of IL-1b were signiﬁcantly suppressed
708(P\0.05) (Fig. 2). Adding 1 lg/ml LPS did not change
the IL-1b secretion. Also stimulation of HUVEC with
1 ng TNFa/ml revealed no signiﬁcant variation after 4
and 8 h. Samples could not be analyzed for IL-1b con-
centration after 24 h since over 80% of cells died.
RAW 264.7 and TNFa In macrophages, control samples
from 4 to 24 h showed a high spontaneous release of
TNFa. Increasing the particle load resulted in reduction of
TNFa after 4–8 h. Only after incubation of 24 h was a
signiﬁcant dose-related stimulation detected (P\0.01)
(data not shown).
RAW 264.7 and IL-6 Signiﬁcant suppression of IL-6
concentration occurred after an incubation period of 8 h
with a particle load of 10 lg/ml. In the remaining sam-
ples, incubation of RAW with glass particles did not show
any dose-related release of IL-6. Incubation with 1 lg/ml
LPS for 4 h revealed a doubling of IL-6 concentration
without any dose-related effects of particles. After 24 h a
signiﬁcant reduction of IL-6 was detected (data not
shown).
Discussion
Our results conﬁrmed the existence of particulate con-
tamination in infusions despite a stringent infusion regime
in the PICU. Different contents of particles were found,
and data suggest that particle exposure is dependent on
the complexity of infusions and medications. These
ﬁndings are in keeping with the results of Mehrkens et al.
[1], who showed that bolus injections mainly increase
particulate contamination of the administered ﬂuids.
Considering the detection limit of 5 lm, the detected
amount underestimates the particle exposure. Fifty per-
cent of the analyzed membranes showed conglomerates
containing uncountable numbers of particles. Smaller
particles were retained in the three-dimensional mesh-
work of the membrane and were disregarded. Most
particles were between 5 and 50 lm, which is more than
the diameter of lung and tissue capillaries [11] and may
cause obstruction. This supports the ﬁndings of Puntis
et al. [4] that particles cause granulomatous arteritis after
parenteral nutrition as demonstrated by post-mortem
study of 73 infants.
In accordance with other authors, we identiﬁed silicon
as a major chemical component [12], which originates
mainly from storage in glass ampoules [13].
Fig. 1 Particle (a) with corresponding EDX analysis (b) and
conglomerate (c) found by electron microscopy on the surface of
different ﬁlters. Presented ﬁlter (a) was used for the application of
bolus injections of multiple different therapeutics via a central
venous line. The size of the particle is approximately 40 9 20 lm.
It shows the representative angular shape and crystalline appear-
ance. In addition to the large particle, many smaller particles and
the incipient blockage of the ﬁlter membrane are apparent. The
corresponding EDX (b) revealed silicon as the major chemical
element. The second ﬁlter (c) was used for high osmolar parenteral
nutrition ([1,300 mosmol/l) via a central venous catheter in a
4-month-old infant after liver transplantation. The EDX analysis
revealed carbon, sodium, chloride, potassium, selene, silicon, and
phosphate as components of the conglomerate
Fig. 2 Interleukin-1beta concentration (pg/ml) after 4, 8 and 24 h
incubation period of HUVEC with different glass particle concen-
trations. After 8 h incubation with glass particles the release of
interleukin-1beta was signiﬁcantly reduced independent from
particle content. Values are mean of four separate assays ±standard
deviation of all samples. *p\0.05; **p\0.01
709In addition to mechanical obstruction, inﬂammatory
response of different organ systems after particle expo-
sure is possible [3, 14, 15]. To mimic these mechanisms,
we exposed macrophages and endothelial cells to particles
similar to those found on the ﬁlters. Our experiments with
endothelial cells showed signiﬁcant suppression of IL-1b
after incubation with particles for 8 and 24 h. Comparable
results were assessed for IL-8. This effect was aggravated
by LPS. In macrophages, different particle loads sup-
pressed the secretion of TNFa. Similar effects were
evident for IL-6, which was signiﬁcantly suppressed after
8 h incubation. Increased IL-8 was found after incubation
with 300–500 lg/ml particles. This was probably due to
cytotoxicity as was seen for comparable particle contents
in pre-tests.
Previously published data suggest an activation of the
immune system by particles [15]. In contrast, our exper-
iments showed a reduced cytokine release. Immune
paralysis is an accepted phenomenon in sepsis or after
ischemia or trauma, as conﬁrmed by clinical and experi-
mental studies [16–19]. The importance of the exact
regulation of the chemokine release and the balance of
pro-inﬂammatory and anti-inﬂammatory mediators in this
phase of the disease is not exactly clear. Small changes
may have an inﬂuence and alter the process of over-
coming the disease. Foreign particles may interfere with
this phase of the disease when the patient is especially
vulnerable.
Lehr et al. [5] demonstrated that stress increases the
harmful effects of particles. Their animal model revealed
a reduction in capillary density in post-ischemic muscles
after particle infusion, in cases without preceding ische-
mia, no change in density was detectable.
A documented beneﬁt of ﬁltration is the prevention of
infusion phlebitis [7]. Less information exists for the
inﬂuence of ﬁltration on severely ill patients. One single-
center trial on 88 preterm newborns showed a trend
toward decreased morbidity in the treatment group [8].
However, the incidence of sepsis could not be reduced by
in-line ﬁltration [20].
According to the data of a preceding analysis, 70% of
our PICU patients were provided with a central-venous
line with three lumina for standardized infusion therapy.
Despite this standard, our examinations demonstrate that
particle exposure continues to be an unpredictable risk for
patients receiving infusion therapy.
Review of literature and our data suggest that particles
are capable of modulating cytokine secretion and may
exert harmful effects beyond mechanical obstruction.
Whether particles affect the outcome of PICU patients has
to be further evaluated.
Acknowledgments We thank Dr. Capewell from the Pall Corpo-
ration for his support and B. Braun and Pall Corporations for the
ﬁnancial support. This study was funded by Pall Corporation,
Dreieich, Germany and B. Braun Corporation, Melsungen, Ger-
many. Dr. Jack and Dr. Sasse received lecture and travel fees form
Pall Corporation and B. Braun Corporation. Dr. Boehne received
travel fees from Pall Corporation. All authors indicate that their
institutions have received research grants from Pall Corporation
and B. Braun Corporation.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are
credited.
References
1. Mehrkens HH, Klaus E, Schmitz JE
(1977) Possibilities of material
contamination due to additional
injections. Klin Anasthesiol
Intensivther 14:106–113
2. Walpot H, Franke RP, Burchard WG,
Agternkamp C, Mu ¨ller FG,
Mittermayer C, Kalff G (1989)
Particulate contamination of infusion
solutions and drug additives within the
scope of long-term intensive therapy. 1:
Energy dispersion electron images in
the scanning electron microscope-
REM/EDX. Anaesthesist 38:544–548
3. Walpot H, Franke RP, Burchard WG,
Agternkamp C, Mu ¨ller FG,
Mittermayer C, Kalff G (1989)
Particulate contamination of infusion
solutions and drug additives in the
framework of long-term intensive
therapy. 2: An animal model.
Anaesthesist 38:617–621
4. Puntis JW, Wilkins KM, Ball PA,
Rushton DI, Booth IW (1992) Hazards
of parenteral treatment: do particles
count? Arch Dis Child 67:1475–1477
5. Lehr HA, Brunner J, Rangoonwala R,
Kirkpatrick CJ (2002) Particulate
matter contamination of intravenous
antibiotics aggravates loss of functional
capillary density in postischemic
striated muscle. Am J Respir Crit Care
Med 165:514–520
6. Schaefer SC, Bison PA, Rangoonwala
R, Kirckpatrick CJ, Lehr HA (2008)
0.2 lm in-line ﬁlters prevent capillary
obstruction by particulate contaminants
of generic antibiotic preparations in
postischemic muscle. Chemother J
17:172–178
7. Falchuk KH, Peterson L, McNeil BJ
(1985) Microparticulate-induced
phlebitis: its prevention by in-line
ﬁltration. N Engl J Med 312:78–82
8. van Lingen RA, Baerts W, Marquering
AC, Ruijs GJ (2004) The use of in-line
intravenous ﬁlters in sick newborn
infants. Acta Paediatr 93:658–662
9. Brent BE, Mu ¨ller M, Jack T (2007)
Harmful effects of infused particles.
Abstract P 44.3.1004. 5th World
Congress on Pediatric Critical Care,
June 24–28, Geneva, Switzerland
10. Dunnett CW (1955) A multiple
comparison procedure for comparing
several treatments with a control. J Am
Stat Assoc 50:1096–1121
11. Levick JR (2003) Introduction to
cardiovascular physiology, 2nd edn.
Oxford University Press, Oxford
12. Oie S, Kamiya A (2005) Particulate and
microbial contamination in in-use
admixed parenteral nutrition solutions.
Biol Pharm Bull 28:2268–2270
71013. Yorioka K, Oie S, Oomaki M, Imamura
A, Kamiya A (2006) Particulate and
microbial contamination in in-use
admixed intravenous infusions. Biol
Pharm Bull 29:2321–2323
14. Hellinger A, Piotrowski J, Konerding
MA, Burchard WG, Doetsch N, Peitgen
K, Erhard J, Reidemeister JC (1997)
Impact of particulate contamination in
crystalloid cardioplegic solutions:
studies by scanning and transmission
electron microscopy. Thorac
Cardiovasc Surg 45:20–26
15. Schulz H, Harder V, Ibald-Mulli A,
Khandoga A, Koenig W, Krombach F,
Radykewicz R, Stampﬂ A, Thorand B,
Peters A (2005) Cardiovascular effects
of ﬁne and ultraﬁne particles. J Aerosol
Med 18:1–22
16. Heidecke CD, Weighardt H, Hensler T,
Bartels H, Holzmann B (2000) Immune
paralysis of T-lymphocytes and
monocytes in postoperative abdominal
sepsis: correlation of immune function
with survival. Chirurg 71:159–165
17. Pinheiro da Silva F, Nizet V (2009) Cell
death during sepsis: integration of
disintegration in the inﬂammatory
response to overwhelming infection.
Apoptosis 14:509–521
18. Wiersinga WJ, van’t Veer C, van den
Pangaart PS, Dondorp AM, Day NP,
Peacock SJ, van der Poll T (2009)
Immunosuppression associated with
interleukin-1R-associated-kinase-M
upregulation predicts mortality in
Gram-negative sepsis (melioidosis).
Crit Care Med 37:569–576
19. Kremer JP, Jarrar D, Steckholzer U,
Ertel W (1996) Interleukin-1,-6 and
tumor necrosis factor-alpha release is
down-regulated in whole blood from
septic patients. Acta Haematol 95:268–
273
20. van den Hoogen A, Krediet TG,
Uiterwaal CS, Bolenius JF, Gerards LJ,
Fleer A (2006) In-line ﬁlters in central
venous catheters in a neonatal intensive
care unit. J Perinat Med 34:71–74
711